Partner News
The section includes updates from partner organizations on related advocacy efforts.
Materials in this section
Progress Towards Elimination of Viral Hepatitis: a Lancet Gastroenterology & Hepatology Commission Update
The Commission update focuses on national progress among the 20 countries most heavily burdened with viral hepatitis (75% of the global burden). An effective response in these countries is crucial if global elimination targets are to be achieved. More
Driving Progress: Funding Hepatitis Elimination Programs for Lasting Impact
By addressing the funding gap through creative financing mechanisms, we can accelerate the progress towards eliminating hepatitis globally. More
World Health Organization Commends Egypt for its Progress on the Path to Eliminate Hepatitis C
Egypt has become the first country to achieve the “gold tier” status on the path to elimination of hepatitis C as per WHO criteria. More
Advocating for the Integration of Viral Hepatitis Prevention and Treatment for People Who Use Drugs in PEPFAR COPs
PEPFAR Watch webinar co-hosted by Treatment Action Group, World Hepatitis Alliance, Harm Reduction International, and the International Drug Policy Consortium. More
The Asia-Pacific Region Has the World’s Highest Burden of Hepatitis B
In an issue brief, amfAR’s TREAT Asia program responds to this urgent global public health emergency pointing out the scope of the problem and what’s needed for the prevention, care, and treatment of people at risk for or impacted by HBV. More
Viral Hepatitis B and C Policies in Countries and Burden of Disease in WHO Regions, 2023
In a fact sheet, WHO provides a status of the viral hepatitis testing and treatment policies as reported through the Global AIDS Monitoring in 2023. More
Chelsea Clinton: How to Eliminate Viral Hepatitis by 2030
Eliminating hepatitis B and C by 2030 will be impossible if donor investments don’t increase. And we aren’t just talking about billion-dollar investments. More
CHAI and The Hepatitis Fund Announce Pricing Breakthrough to Reduce Cost of Viral Hepatitis Treatment by Over 90 Percent
Memoranda of Understanding with leading generic manufacturers to secure historic ceiling prices for life-saving hepatitis B and C treatments. More
As Evidence Mounts That ‘War on Drugs’ Has Failed, Harm Reduction Advocates Call for New Policies
Leading proponents of drug-policy reform who have gathered at the International Harm Reduction Conference say the evidence is in that it is time for the world to adopt a new approach. More
Unitaid Makes US$31 Million Investment in Harm Reduction Efforts to Prevent Hepatitis C Among People who Inject Drugs and Others at High Risk
Unitaid’s funding will support the integration of hepatitis C testing and treatment within harm reduction programs and trial the use of two products to prevent infection. More
